KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+0.52%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$955M
AUM Growth
+$955M
(+6.3%)
Cap. Flow
+$18M
Cap. Flow
% of AUM
1.88%
Top 10 Holdings %
Top 10 Hldgs %
87.58%
Holding
27
New
1
Increased
17
Reduced
3
Closed
–
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$31.9M |
| 2 |
Viridian Therapeutics
VRDN
|
$21M |
| 3 |
Celldex Therapeutics
CLDX
|
$18.1M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$14.2M |
| 5 |
Cogent Biosciences
COGT
|
$6.41M |
Top Sells
| 1 |
BNR
Burning Rock Biotech
BNR
|
$55.9M |
| 2 |
Liquidia Corp
LQDA
|
$16M |
| 3 |
Protagonist Therapeutics
PTGX
|
$11.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| – | – | 0 | – | – |
|